Clinical Trial Update: Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma [NA]

View source ↗

Summary

An ongoing radiation dose study for relapsed/refractory Hodgkin lymphoma and non-Hodgkin lymphoma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Chicago | Conditions: Non-hodgkin Lymphoma, Hodgkin Lymphoma | NA | Status: ACTIVE_NOT_RECRUITING